| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 05/27/2009 | EP1095275B1 Endogenous constitutively activated g protein-coupled orphan receptors |
| 05/27/2009 | CN101443329A Polymorphs of n-(4-chloro-3-methyl-5-isoxazolyl) 2-[2-methyl-4,5-(methylenedioxy)phenylacetyl] thiophene-3-sulfonamide, sodium salt |
| 05/27/2009 | CN101443323A Substituted spirocyclic CGRP receptor antagonists |
| 05/27/2009 | CN101443318A Heterobicyclic carboxamides as inhibitors for kinases |
| 05/27/2009 | CN101443316A 1,5-diphenylpyrazoles II as HSP90 inhibitors |
| 05/27/2009 | CN101440090A 2-(6'-imine pyridinyl) benzoxazole metal complexes, as well as preparation method and application thereof |
| 05/27/2009 | CN101440089A Compositions, methods and kits pertaining to luminescent compounds |
| 05/27/2009 | CN101440062A Synthesis of N-acyl-8-amino quinoline derivatives and use thereof as fluorescent molecular probe |
| 05/27/2009 | CN101439191A Visible light induced zinc ion fluorescence angiographic reagent capable of being applied in cell/tissue/living body as well as synthesizing method and applications |
| 05/27/2009 | CN100491368C Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 05/27/2009 | CN100491360C Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors |
| 05/27/2009 | CN100491359C 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators |
| 05/27/2009 | CN100491355C Cyclic diamine compound having five-membered cyclic group |
| 05/27/2009 | CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 05/27/2009 | CN100491349C Antiviral agent |
| 05/26/2009 | US7538222 Such as N-{1-[2-(1,3-dioxan-2-yl)ethyl]piperidin-4-yl}-N-(4-fluorobenzyl)-2-[4-(2-hydroxy-2-methylpropoxy)phenyl]acetamide; selective inverse agonists of 5-HT2A receptor with minimal monamine receptors subtype activity; antipsychotics with reduced side effects |
| 05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/26/2009 | US7538138 Histamine-3 receptor antagonists; 4-(2-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-1-benzofuran-4-yl)benzonitrile; acute myocardial infarction, asthma, psychological disorders, gastrointestinal disorders, inflammation, jet lag, cancer, septic shock, Tourette's syndrome, neurodegenerative disorders |
| 05/26/2009 | US7538135 Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds |
| 05/26/2009 | US7538132 aryl-isoxazole-4-carbonyl-pyrrole-2-carboxylic acid amide derivatives; cognitive disorders like Alzheimer's disease; high affinity and selectivity for GABA A alpha 5 receptors; 4-[3-(4-Chloro-phenyl)-5-methyl-isoxazole-4-carbonyl]-1H-pyrrole-2-carboxylic acid prop-2-ynylamide |
| 05/26/2009 | US7538123 Indole derivative having piperidine ring |
| 05/26/2009 | US7538107 Oxazinan-2-one derivatives useful as PR modulators |
| 05/26/2009 | CA2474373C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substituent on the methyl useful as bradykinin antagonists |
| 05/26/2009 | CA2393821C Substituted imidazole neuropeptide y y5 receptor antagonists |
| 05/26/2009 | CA2367017C Inhibitors of impdh enzyme |
| 05/26/2009 | CA2354774C Farnesyl protein transferase inhibitors |
| 05/26/2009 | CA2340701C Oxindole derivatives as growth hormone releasers |
| 05/26/2009 | CA2216653C 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity |
| 05/22/2009 | WO2009064835A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
| 05/22/2009 | WO2009063953A1 Phenylpyrazole derivatives |
| 05/22/2009 | WO2009063910A1 Method for catalytic asymmetric synthesis of optically active isoxazoline compound |
| 05/22/2009 | WO2009063061A2 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 05/22/2009 | WO2009063028A2 Substituted amides, manufacturing and use thereof as medicaments |
| 05/22/2009 | WO2009062289A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | WO2009062285A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | WO2009034028A3 Novel compounds |
| 05/22/2009 | WO2009010260A3 Condensed anthranilamide insecticides |
| 05/22/2009 | WO2008034032A3 Beta-lactam cannabinoid receptor modulators |
| 05/22/2009 | CA2707418A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | CA2705502A1 Phenylpyrazole derivatives |
| 05/22/2009 | CA2705318A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | CA2704628A1 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 05/22/2009 | CA2704599A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
| 05/21/2009 | US20090131659 Amide compound and thrombopoietin receptor activator |
| 05/21/2009 | US20090131483 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 05/21/2009 | US20090131463 Novel compounds |
| 05/21/2009 | US20090131461 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
| 05/21/2009 | US20090131438 Triazole derivative |
| 05/21/2009 | US20090131437 Disubstituted ureas as kinase inhibitors |
| 05/21/2009 | US20090131436 Pyrimidine Derivatives |
| 05/21/2009 | US20090131435 Heterocyclic inhibitors of mek and methods of use |
| 05/21/2009 | US20090131434 such as E-4-[(2-methyl-2-{[4-(trifluoromethyl)benzyl]oxy}propanoyl)amino]adamantane-1-carboxamide, used for the treatment of non-insulin dependent diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, dementia, psychosis, depression or anxiety |
| 05/21/2009 | US20090131433 such as 3-(3-Acetyl-phenyl)-1-[3-(3-chloro-4-pyrrolidin-1-ylmethyl-phenoxy)-cyclobutylmethyl]-1-methyl-urea, used for the treatment of , schizophrenia, Alzheimer's disease, attention-deficit hyperactivity disorder, hypotension, allergies, cardiovascular, gastrointestinal and psychological disorders |
| 05/21/2009 | US20090131428 Benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 05/21/2009 | US20090131423 Tyrosine Kinase Inhibitors |
| 05/21/2009 | US20090131422 Salts of an IKK inhibitor |
| 05/21/2009 | US20090131420 Novel Heterocyclic Analogs of Biphenyl Ethers |
| 05/21/2009 | US20090131412 Novel 2-quinolone derivative |
| 05/21/2009 | US20090131411 monoamidino-containing compounds having good bioavailability and/or solubility, used as potent and specific inhibitors of blood coagulation in mammals, and as therapeutic agents for disease states characterized by coagulation disorders |
| 05/21/2009 | US20090131403 Nitrogenated heterocyclic derivative , and pharmaceutical agent comprising the derivative as active ingredient |
| 05/21/2009 | US20090131401 Transcription factor modulating compounds and methods of use thereof |
| 05/21/2009 | US20090131397 Estrogen modulators |
| 05/21/2009 | US20090131336 Isoxazole Derivatives and Use Thereof |
| 05/21/2009 | US20090130209 Novel Pyridazinone Derivatives |
| 05/21/2009 | US20090130117 Substituted Tetrazole Compounds and Uses Thereof |
| 05/20/2009 | EP2060570A2 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors |
| 05/20/2009 | EP2060563A1 Cyclic aminoalkylcarboxamide derivative |
| 05/20/2009 | EP2060260A1 Therapeutic agents useful for treating pain |
| 05/20/2009 | EP2059516A1 Pyridine compounds for treating gpr119 related disorders |
| 05/20/2009 | EP2059515A2 Pyrrolidine derivatives as modulators of chemokine ccr5 receptors |
| 05/20/2009 | EP1883302A4 Jak kinase inhibitors and their uses |
| 05/20/2009 | EP1365760B1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 05/20/2009 | CN101437818A Novel dual action receptors antagonists (DARA) at the AT1 and ETA receptors |
| 05/20/2009 | CN101437815A Polycyclic heterocyclic compounds and their use as modulators of the metabotropic glutamate 5 receptor |
| 05/20/2009 | CN101437813A Mglur5 modulators III |
| 05/20/2009 | CN101437805A Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments |
| 05/20/2009 | CN101437800A Compounds and compositions as HEDGEHOG pathway modulators |
| 05/20/2009 | CN101437798A Mglur5 modulators II |
| 05/20/2009 | CN101434603A Compound containing carbazolyl and 1,3,4-oxdiazole and preparation thereof |
| 05/20/2009 | CN101434602A Compound containing carrier transport group and preparation thereof |
| 05/20/2009 | CN100488960C 2-substituted quinolone compound and use in pharmacy |
| 05/20/2009 | CN100488958C 3-substituted-4-pyrimidone derivatives |
| 05/20/2009 | CN100488510C Morpholine derivatives for use as dopamine agonists in the treatment of I.A. sexual dysfunction |
| 05/20/2009 | CN100488506C 5-membered heterocycle derivatives, production thereof and use as medicaments |
| 05/20/2009 | CN100488504C Novel coumarin-amide derivatives and its preparation, its drug composition and use |
| 05/19/2009 | US7534887 Thiazoline derivative and use of the same |
| 05/19/2009 | US7534801 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands |
| 05/19/2009 | US7534798 Vanilloid receptor ligands and their use in treatments |
| 05/19/2009 | US7534794 Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
| 05/19/2009 | US7534793 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria |
| 05/19/2009 | US7534791 e.g. [2-(Benzo[b]furan-3-ylsulfanyl)-benzyl]-methyl-amine; serotonin and noradrenaline reuptake inhibitors; antidepressant, anxiolytic agent, pdychological disorders, analgesic, neurodegenerative diseases |
| 05/19/2009 | US7534790 Aminocyclohexyl ether compounds such as trans-[2-(4-morpholinyl)-1-(2-naphthenethoxy)]cyclohexane; arrhythmia, analgesia and local anesthesia |
| 05/19/2009 | US7534789 Enantiomeric pure β agonists, manufacturing and use as a medicament thereof |
| 05/19/2009 | US7534784 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide |
| 05/19/2009 | US7534421 Water solubility; photostability; sunscreen agents; ultraviolet radiation B and A absorbers |
| 05/19/2009 | CA2498047C Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
| 05/19/2009 | CA2368059C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 05/19/2009 | CA2230931C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 05/19/2009 | CA2211381C Compounds with growth hormone releasing properties |
| 05/19/2009 | CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |